摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

dinitrato(benzylbis[2-(3,5-dimethyl-1-pyrazolyl)ethyl]amine)copper(II) | 167224-26-2

中文名称
——
中文别名
——
英文名称
dinitrato(benzylbis[2-(3,5-dimethyl-1-pyrazolyl)ethyl]amine)copper(II)
英文别名
copper;N-benzyl-2-(3,5-dimethylpyrazol-1-yl)-N-[2-(3,5-dimethylpyrazol-1-yl)ethyl]ethanamine;dinitrate
dinitrato(benzylbis[2-(3,5-dimethyl-1-pyrazolyl)ethyl]amine)copper(II)化学式
CAS
167224-26-2
化学式
C21H29CuN7O6
mdl
——
分子量
539.051
InChiKey
MYSDNQNQAHICSG-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    None
  • 重原子数:
    None
  • 可旋转键数:
    None
  • 环数:
    None
  • sp3杂化的碳原子比例:
    None
  • 拓扑面积:
    None
  • 氢给体数:
    None
  • 氢受体数:
    None

反应信息

  • 作为产物:
    参考文献:
    名称:
    X-ray Structures and Redox Properties of Copper(II) Bis(pyrazole) Complexes
    摘要:
    The copper complexes of bis[2-(3,5-dimethyl-1-pyrazolyl)ethyl] amine (1) and its benzylated derivative (2) have been studied as single crystals by X-ray crystallography and as powders and solutions by a variety of techniques. [Cu(1). 2NO(3)] (C14H25CuN7O7 including 1 H2O, 3) crystallized in the monoclinic space group Pc (No. 7) with a = 8.1596(9) Angstrom, b = 31.164(2) Angstrom, c = 7.7966(9) Angstrom, beta = 94.75(2)degrees, V = 1975.7(3) Angstrom(3), and Z = 4 (structure refinement converged to R(F) = 0.066 and R(wF)(2) = 0.227); [Cu(1)ClO4 . C2H5OH]ClO4 (C16H29Cl2CuN5O9, 4) crystallized in the orthorhombic space group Pna2(1) (No. 33) with a = 13.3463(7) Angstrom, b = 10.3925(9) Angstrom, c = 17.511(1) Angstrom, V = 2432.1(3) Angstrom(3), and Z = 4 (refined to R(F) = 0.063 and R(wF) = 0.052); [Cu(2). 2NO(3)] (C21H29CuN7O6, 5) crystallized in the monoclinic space group C2/c (No. 15) with a = 28.719(2) Angstrom, b = 8.6043(6) Angstrom, c = 23.034(2) Angstrom, beta = 124.767(7)degrees, V = 4675.7(7) Angstrom(3), and Z = 8 (refined to R(F) = 0.042 and R(wF) = 0.034); [Cu .(2). C2H5OH . Y](ClO4)(n) (C48H78Cl4Cu2N10O20, 6) (Y = H2O, n = 2, or ClO4-, n = 1) crystallized in the monoclinic space group P2(1)/c (No. 14) with a = 10.9488(9) Angstrom, b = 17.030(2) Angstrom, c = 32.893(3) Angstrom, beta = 92.185(7)degrees, V = 6129(1) Angstrom(3) and Z = 4 (refined to R(F) = 0.104 and R(wF) = 0.119). In complexes 3, 4, and 6, the ligand coordinated Cu(II) with a T-shaped arrangement of the nitrogen donor atoms. Ethanol coordinated in one of the apical positions in complexes 4 and 6. The amine nitrogen moved from the basal plane in 3 to the apical position in 5, where the copper had square pyramidal coordination geometry. The largest difference between 4 and 6 was a lengthening of 0.1 Angstrom in the bond between the Cu(II) and the amine nitrogen. Conductivity measurements revealed that the nitrate complexes behave as 1:1 electrolytes in acetonitrile solution, whereas the perchlorate complexes behaved as 2:1 electrolytes. The half-wave potentials, measured in acetonitrile by cyclic voltammetry, were -0.01, +0.15, +0.10, and +0.28 V for 3-6, respectively. The high redox potentials of the copper(II) bis(pyrazole) complexes, in particular for complex 6, are explained by the fact that the Cu(II) complexes have the correct ligand geometry for the stabilization of Cu(I).
    DOI:
    10.1021/ic00123a005
点击查看最新优质反应信息

同类化合物

()-2-(5-甲基-2-氧代苯并呋喃-3(2)-亚乙基)乙酸乙酯 (双(2,2,2-三氯乙基)) (乙基N-(1H-吲唑-3-基羰基)ethanehydrazonoate) (Z)-3-[[[2,4-二甲基-3-(乙氧羰基)吡咯-5-基]亚甲基]吲哚-2--2- (S)-(-)-5'-苄氧基苯基卡维地洛 (S)-(-)-2-(α-(叔丁基)甲胺)-1H-苯并咪唑 (S)-(-)-2-(α-甲基甲胺)-1H-苯并咪唑 (S)-氨氯地平-d4 (S)-8-氟苯并二氢吡喃-4-胺 (S)-4-(叔丁基)-2-(喹啉-2-基)-4,5-二氢噁唑 (S)-4-氯-1,2-环氧丁烷 (S)-3-(2-(二氟甲基)吡啶-4-基)-7-氟-3-(3-(嘧啶-5-基)苯基)-3H-异吲哚-1-胺 (S)-2-(环丁基氨基)-N-(3-(3,4-二氢异喹啉-2(1H)-基)-2-羟丙基)异烟酰胺 (SP-4-1)-二氯双(喹啉)-钯 (SP-4-1)-二氯双(1-苯基-1H-咪唑-κN3)-钯 (R,S)-可替宁N-氧化物-甲基-d3 (R,S)-六氢-3H-1,2,3-苯并噻唑-2,2-二氧化物-3-羧酸叔丁酯 (R)-(+)-5'-苄氧基卡维地洛 (R)-(+)-2,2'',6,6''-四甲氧基-4,4''-双(二苯基膦基)-3,3''-联吡啶(1,5-环辛二烯)铑(I)四氟硼酸盐 (R)-卡洛芬 (R)-N'-亚硝基尼古丁 (R)-DRF053二盐酸盐 (R)-4-异丙基-2-恶唑烷硫酮 (R)-3-甲基哌啶盐酸盐; (R)-2-苄基哌啶-1-羧酸叔丁酯 (N-(Boc)-2-吲哚基)二甲基硅烷醇钠 (N-{4-[(6-溴-2-氧代-1,3-苯并恶唑-3(2H)-基)磺酰基]苯基}乙酰胺) (E)-2-氰基-3-(5-(2-辛基-7-(4-(对甲苯基)-1,2,3,3a,4,8b-六氢环戊[b]吲哚-7-基)-2H-苯并[d][1,2,3]三唑-4-基)噻吩-2-基)丙烯酸 (E)-2-氰基-3-[5-(2,5-二氯苯基)呋喃-2-基]-N-喹啉-8-基丙-2-烯酰胺 (8α,9S)-(+)-9-氨基-七氢呋喃-6''-醇,值90% (6R,7R)-7-苯基乙酰胺基-3-[(Z)-2-(4-甲基噻唑-5-基)乙烯基]-3-头孢唑啉-4-羧酸二苯甲基酯 (6-羟基嘧啶-4-基)乙酸 (6,7-二甲氧基-4-(3,4,5-三甲氧基苯基)喹啉) (6,6-二甲基-3-(甲硫基)-1,6-二氢-1,2,4-三嗪-5(2H)-硫酮) (5aS,6R,9S,9aR)-5a,6,7,8,9,9a-六氢-6,11,11-三甲基-2-(2,3,4,5,6-五氟苯基)-6,9-甲基-4H-[1,2,4]三唑[3,4-c][1,4]苯并恶嗪四氟硼酸酯 (5R,Z)-3-(羟基((1R,2S,6S,8aS)-1,3,6-三甲基-2-((E)-prop-1-en-1-yl)-1,2,4a,5,6,7,8,8a-八氢萘-1-基)亚甲基)-5-(羟甲基)-1-甲基吡咯烷-2,4-二酮 (5E)-5-[(2,5-二甲基-1-吡啶-3-基-吡咯-3-基)亚甲基]-2-亚磺酰基-1,3-噻唑烷-4-酮 (5-(4-乙氧基-3-甲基苄基)-1,3-苯并二恶茂) (5-溴-3-吡啶基)[4-(1-吡咯烷基)-1-哌啶基]甲酮 (5-氯-2,1,3-苯并噻二唑-4-基)-氨基甲氨基硫代甲酸甲酯一氢碘 (5-氨基-6-氰基-7-甲基[1,2]噻唑并[4,5-b]吡啶-3-甲酰胺) (5-氨基-1,3,4-噻二唑-2-基)甲醇 (4aS-反式)-八氢-1H-吡咯并[3,4-b]吡啶 (4aS,9bR)-6-溴-2,3,4,4a,5,9b-六氢-1H-吡啶并[4,3-B]吲哚 (4S,4''S)-2,2''-环亚丙基双[4-叔丁基-4,5-二氢恶唑] (4-(4-氯苯基)硫代)-10-甲基-7H-benzimidazo(2,1-A)奔驰(德)isoquinolin-7一 (4-苄基-2-甲基-4-nitrodecahydropyrido〔1,2-a][1,4]二氮杂) (4-甲基环戊-1-烯-1-基)(吗啉-4-基)甲酮 (4-己基-2-甲基-4-nitrodecahydropyrido〔1,2-a][1,4]二氮杂) (4,5-二甲氧基-1,2,3,6-四氢哒嗪)